528 related articles for article (PubMed ID: 15674295)
1. APOBEC3G cytidine deaminase inhibits retrotransposition of endogenous retroviruses.
Esnault C; Heidmann O; Delebecque F; Dewannieux M; Ribet D; Hance AJ; Heidmann T; Schwartz O
Nature; 2005 Jan; 433(7024):430-3. PubMed ID: 15674295
[TBL] [Abstract][Full Text] [Related]
2. Dual inhibitory effects of APOBEC family proteins on retrotransposition of mammalian endogenous retroviruses.
Esnault C; Millet J; Schwartz O; Heidmann T
Nucleic Acids Res; 2006; 34(5):1522-31. PubMed ID: 16537839
[TBL] [Abstract][Full Text] [Related]
3. Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts.
Mangeat B; Turelli P; Caron G; Friedli M; Perrin L; Trono D
Nature; 2003 Jul; 424(6944):99-103. PubMed ID: 12808466
[TBL] [Abstract][Full Text] [Related]
4. The DNA deaminase activity of human APOBEC3G is required for Ty1, MusD, and human immunodeficiency virus type 1 restriction.
Schumacher AJ; Haché G; Macduff DA; Brown WL; Harris RS
J Virol; 2008 Mar; 82(6):2652-60. PubMed ID: 18184715
[TBL] [Abstract][Full Text] [Related]
5. The APOBEC3 cytidine deaminases: an innate defensive network opposing exogenous retroviruses and endogenous retroelements.
Chiu YL; Greene WC
Annu Rev Immunol; 2008; 26():317-53. PubMed ID: 18304004
[TBL] [Abstract][Full Text] [Related]
6. The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA.
Zhang H; Yang B; Pomerantz RJ; Zhang C; Arunachalam SC; Gao L
Nature; 2003 Jul; 424(6944):94-8. PubMed ID: 12808465
[TBL] [Abstract][Full Text] [Related]
7. APOBEC3G hypermutates genomic DNA and inhibits Ty1 retrotransposition in yeast.
Schumacher AJ; Nissley DV; Harris RS
Proc Natl Acad Sci U S A; 2005 Jul; 102(28):9854-9. PubMed ID: 16000409
[TBL] [Abstract][Full Text] [Related]
8. Selective inhibition of Alu retrotransposition by APOBEC3G.
Hulme AE; Bogerd HP; Cullen BR; Moran JV
Gene; 2007 Apr; 390(1-2):199-205. PubMed ID: 17079095
[TBL] [Abstract][Full Text] [Related]
9. APOBEC3G is a single-stranded DNA cytidine deaminase and functions independently of HIV reverse transcriptase.
Suspène R; Sommer P; Henry M; Ferris S; Guétard D; Pochet S; Chester A; Navaratnam N; Wain-Hobson S; Vartanian JP
Nucleic Acids Res; 2004; 32(8):2421-9. PubMed ID: 15121899
[TBL] [Abstract][Full Text] [Related]
10. Intrinsic restriction activity by apolipoprotein B mRNA editing enzyme APOBEC1 against the mobility of autonomous retrotransposons.
Ikeda T; Abd El Galil KH; Tokunaga K; Maeda K; Sata T; Sakaguchi N; Heidmann T; Koito A
Nucleic Acids Res; 2011 Jul; 39(13):5538-54. PubMed ID: 21398638
[TBL] [Abstract][Full Text] [Related]
11. Restriction by APOBEC3 proteins of endogenous retroviruses with an extracellular life cycle: ex vivo effects and in vivo "traces" on the murine IAPE and human HERV-K elements.
Esnault C; Priet S; Ribet D; Heidmann O; Heidmann T
Retrovirology; 2008 Aug; 5():75. PubMed ID: 18702815
[TBL] [Abstract][Full Text] [Related]
12. Restriction of foamy viruses by APOBEC cytidine deaminases.
Delebecque F; Suspène R; Calattini S; Casartelli N; Saïb A; Froment A; Wain-Hobson S; Gessain A; Vartanian JP; Schwartz O
J Virol; 2006 Jan; 80(2):605-14. PubMed ID: 16378963
[TBL] [Abstract][Full Text] [Related]
13. Characterization of APOBEC3G binding to 7SL RNA.
Bach D; Peddi S; Mangeat B; Lakkaraju A; Strub K; Trono D
Retrovirology; 2008 Jul; 5():54. PubMed ID: 18597676
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of a yeast LTR retrotransposon by human APOBEC3 cytidine deaminases.
Dutko JA; Schäfer A; Kenny AE; Cullen BR; Curcio MJ
Curr Biol; 2005 Apr; 15(7):661-6. PubMed ID: 15823539
[TBL] [Abstract][Full Text] [Related]
15. Extensive editing of both hepatitis B virus DNA strands by APOBEC3 cytidine deaminases in vitro and in vivo.
Suspène R; Guétard D; Henry M; Sommer P; Wain-Hobson S; Vartanian JP
Proc Natl Acad Sci U S A; 2005 Jun; 102(23):8321-6. PubMed ID: 15919829
[TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein B mRNA-editing, catalytic polypeptide cytidine deaminases and retroviral restriction.
Koito A; Ikeda T
Wiley Interdiscip Rev RNA; 2012; 3(4):529-41. PubMed ID: 22549984
[TBL] [Abstract][Full Text] [Related]
17. APOBEC3G & HTLV-1: inhibition without deamination.
Strebel K
Retrovirology; 2005 May; 2():37. PubMed ID: 15921532
[TBL] [Abstract][Full Text] [Related]
18. High-molecular-mass APOBEC3G complexes restrict Alu retrotransposition.
Chiu YL; Witkowska HE; Hall SC; Santiago M; Soros VB; Esnault C; Heidmann T; Greene WC
Proc Natl Acad Sci U S A; 2006 Oct; 103(42):15588-93. PubMed ID: 17030807
[TBL] [Abstract][Full Text] [Related]
19. Functional central polypurine tract provides downstream protection of the human immunodeficiency virus type 1 genome from editing by APOBEC3G and APOBEC3B.
Wurtzer S; Goubard A; Mammano F; Saragosti S; Lecossier D; Hance AJ; Clavel F
J Virol; 2006 Apr; 80(7):3679-83. PubMed ID: 16537639
[TBL] [Abstract][Full Text] [Related]
20. Cytidine deaminases APOBEC3G and APOBEC3F interact with human immunodeficiency virus type 1 integrase and inhibit proviral DNA formation.
Luo K; Wang T; Liu B; Tian C; Xiao Z; Kappes J; Yu XF
J Virol; 2007 Jul; 81(13):7238-48. PubMed ID: 17428847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
